The clinical-stage company focuses on researching, developing, and commercializing transformative therapies for cancer and other inflammatory conditions. Founded in 2017 and headquartered in New York, Flame Biosciences' platform aims to improve the lives of patients suffering from debilitating and life-threatening diseases by offering the right treatment for those with high chronic inflammation.